For the quarter ending 2025-09-30, COLL has $1,607,328K in assets. $1,332,520K in debts. $150,096K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 150,096 | 117,348 | ||
| Marketable securities | 135,767 | 104,805 | ||
| Accounts receivable, net | 233,949 | 213,023 | ||
| Inventory | 38,052 | 38,148 | ||
| Prepaid expenses and other current assets | 36,156 | 56,037 | ||
| Restricted cash | 19,850 | 19,850 | ||
| Total current assets | 613,870 | 549,211 | ||
| Property and equipment, net | 12,249 | 12,903 | ||
| Operating lease assets | 4,432 | 5,263 | ||
| Intangible assets, net | 724,983 | 780,456 | ||
| Restricted cash | 1,054 | 1,050 | ||
| Deferred tax assets | 102,477 | 91,967 | ||
| Other noncurrent assets | 2,338 | 3,845 | ||
| Goodwill | 145,925 | 147,936 | ||
| Total assets | 1,607,328 | 1,592,631 | ||
| Accounts payable | 7,647 | 10,890 | ||
| Accrued liabilities | 51,468 | 59,436 | ||
| Accrued rebates, returns and discounts | 309,608 | 310,758 | ||
| Current portion of term notes payable | 64,583 | 64,583 | ||
| Current portion of operating lease liabilities | 1,372 | 1,338 | ||
| Business combination consideration payable | 17,565 | 17,566 | ||
| Contingent consideration | 19 | 38 | ||
| Deferred revenue | 667 | - | ||
| Total current liabilities | 452,929 | 464,609 | ||
| Term notes payable, net of current portion | 505,583 | 520,648 | ||
| Convertible senior notes | 237,950 | 237,688 | ||
| Operating lease liabilities, net of current portion | 4,501 | 4,853 | ||
| Deferred royalty obligation | 122,279 | 122,627 | ||
| Deferred revenue, net of current portion | 9,278 | 10,000 | ||
| Total liabilities | 1,332,520 | 1,360,425 | ||
| Common stock, 0.001 par value authorized shares - 100,000,000 40,629,601 issued and 31,600,879 outstanding shares as of september 30, 2025 and 39,646,749 issued and 31,440,155 outstanding shares as of december 31, 2024 | 41 | 40 | ||
| Additional paid-in capital | 615,077 | 598,938 | ||
| Treasury stock, at cost 9,028,722 shares as of september 30, 2025 and 8,206,594 shares as of december 31, 2024 | 222,510 | 217,510 | ||
| Accumulated other comprehensive income | 292 | 337 | ||
| Accumulated deficit | -118,092 | -149,599 | ||
| Total shareholders' equity | 274,808 | 232,206 | ||
| Total liabilities and shareholders' equity | 1,607,328 | 1,592,631 | ||
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)